124 related articles for article (PubMed ID: 29795419)
1. Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
Jacobse J; Mensink H; van der Stoep-Yap MYEC; Kollen WJW; Bresters D; Bredius RGM
Bone Marrow Transplant; 2018 Oct; 53(10):1372-1374. PubMed ID: 29795419
[No Abstract] [Full Text] [Related]
2. [Hemophagocytic lymphohistiocytosis].
Imamura Y
Rinsho Ketsueki; 2014 Feb; 55(2):223-33. PubMed ID: 24598190
[No Abstract] [Full Text] [Related]
3. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation.
Brand RE; DiBaise JK; Quigley EM; Gobar LS; Harmon KS; Lynch JC; Bierman PJ; Bishop MR; Tarantolo SR
Lancet; 1998 Dec 19-26; 352(9145):1985. PubMed ID: 9872252
[No Abstract] [Full Text] [Related]
4. Gastroparesis-associated refractory nausea treated with aprepitant.
Fahler J; Wall GC; Leman BI
Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
[TBL] [Abstract][Full Text] [Related]
5. Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
Richards S; Choo S; Mechinaud F; Cole T
Bone Marrow Transplant; 2018 Jun; 53(6):784-786. PubMed ID: 29535382
[No Abstract] [Full Text] [Related]
6. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
Stapleton J; Wo JM
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine Reduces Chemotherapy-induced Nausea and Vomiting Compared With Aprepitant in Myeloma Patients Receiving High-dose Melphalan Before Stem Cell Transplantation: A Retrospective Study.
Trifilio S; Welles C; Seeger K; Mehta S; Fishman M; McGowan K; Strejcek K; Eiten E; Pirotte C; Lucier E; DeFrates S; Mehta J
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):584-589. PubMed ID: 28694084
[TBL] [Abstract][Full Text] [Related]
8. Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Oddby-Muhrbeck E; Öbrink E; Eksborg S; Rotstein S; Lönnqvist PA
Acta Anaesthesiol Scand; 2013 Jul; 57(6):749-53. PubMed ID: 23281590
[TBL] [Abstract][Full Text] [Related]
9. Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen.
Sweiss K; Oh A; Calip G; Rondelli D; Patel P
Bone Marrow Transplant; 2018 Sep; 53(9):1221-1224. PubMed ID: 29703968
[No Abstract] [Full Text] [Related]
10. Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions.
Tendas A; Marchesi F; Mengarelli A; Annibali O; Tomarchio V; Saltarelli D; Chierichini A; Di Venanzio M; Sollazzo F; Piedimonte M; Cupelli L; Bruno A; De Angelis G; Delbono L; Niscola P; Perrotti AP; de Fabritiis P; Arcese W;
Support Care Cancer; 2019 Mar; 27(3):793-803. PubMed ID: 30564934
[TBL] [Abstract][Full Text] [Related]
11. Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation.
Nordesjö-Haglund G; Lönnqvist B; Lindberg G; Hellström-Lindberg E
Lancet; 1999 Mar; 353(9155):846. PubMed ID: 10459993
[No Abstract] [Full Text] [Related]
12. A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT).
Bubalo J; Mulverhill K; Meyers G; Hayes-Lattin B; Maziarz R
Bone Marrow Transplant; 2018 Aug; 53(8):1010-1018. PubMed ID: 29459665
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
[TBL] [Abstract][Full Text] [Related]
14. IV aprepitant (Cinvanti) for chemotherapy-induced nausea and vomiting.
Med Lett Drugs Ther; 2018 Dec; 60(1561):e200-e201. PubMed ID: 30653479
[No Abstract] [Full Text] [Related]
15. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Kröger N; Shimoni A; Zabelina T; Schieder H; Panse J; Ayuk F; Wolschke C; Renges H; Dahlke J; Atanackovic D; Nagler A; Zander A
Bone Marrow Transplant; 2006 Feb; 37(4):339-44. PubMed ID: 16415898
[TBL] [Abstract][Full Text] [Related]
16. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
Bornhäuser M; Thiede C; Platzbecker U; Jenke A; Helwig A; Plettig R; Freiberg-Richter J; Röllig C; Geissler G; Lutterbeck K; Oelschlagel U; Ehninger G
Clin Cancer Res; 2001 Aug; 7(8):2254-62. PubMed ID: 11489799
[TBL] [Abstract][Full Text] [Related]
17. Triple drug combination in the prevention of nausea and vomiting following busulfan plus cyclophosphamide chemotherapy before allogeneic hematopoietic stem cell transplantation.
Pielichowski W; Gawronski K; Mlot B; Oborska S; Wasko-Grabowska A; Rzepecki P
J BUON; 2011; 16(3):541-6. PubMed ID: 22006763
[TBL] [Abstract][Full Text] [Related]
18. Nausea and vomiting in diabetic and idiopathic gastroparesis.
Cherian D; Parkman HP
Neurogastroenterol Motil; 2012 Mar; 24(3):217-22, e103. PubMed ID: 22118574
[TBL] [Abstract][Full Text] [Related]
19. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
20. Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.
Jenke A; Freiberg-Richter J; Johne C; Knoth H; Schleyer E; Ehninger G; Bornhäuser M
Bone Marrow Transplant; 2005 Mar; 35(6):627-8. PubMed ID: 15756286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
